{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:10:22Z","timestamp":1780488622090,"version":"3.54.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12025-0","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:20:16Z","timestamp":1780485616000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Increased Carbapenem resistance and gene carriage in Pseudomonas aeruginosa clinical isolates after the COVID-19 pandemic in Egypt"],"prefix":"10.1007","volume":"53","author":[{"given":"Soha S.","family":"Abdelrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaimaa","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia N.","family":"Kotb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"issue":"1","key":"12025_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41392-022-01056-1","volume":"7","author":"S Qin","year":"2022","unstructured":"Qin S, Xiao W, Zhou C, Pu Q, Deng X, Lan L, Liang H, Song X, Wu M (2022) Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduct Target therapy 7(1):199. https:\/\/doi.org\/10.1038\/s41392-022-01056-1","journal-title":"Signal Transduct Target therapy"},{"issue":"1","key":"12025_CR2","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1080\/22221751.2022.2048972","volume":"11","author":"FC Tenover","year":"2022","unstructured":"Tenover FC, Nicolau DP, Gill CM (2022) Carbapenemase-producing Pseudomonas aeruginosa -an emerging challenge. Emerg microbes infections 11(1):811\u2013814. https:\/\/doi.org\/10.1080\/22221751.2022.2048972","journal-title":"Emerg microbes infections"},{"issue":"3","key":"12025_CR3","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3390\/antibiotics11030421","volume":"11","author":"C Aurilio","year":"2022","unstructured":"Aurilio C, Sansone P, Barbarisi M, Pota V, Giaccari LG, Coppolino F, Barbarisi A, Passavanti MB, Pace MC (2022) Mechanisms of Action of Carbapenem Resistance. Antibiot (Basel Switzerland) 11(3):421. https:\/\/doi.org\/10.3390\/antibiotics11030421","journal-title":"Antibiot (Basel Switzerland)"},{"key":"12025_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2147\/IDR.S346313","volume":"15","author":"Y Park","year":"2022","unstructured":"Park Y, Koo SH (2022) Epidemiology, Molecular Characteristics, and Virulence Factors of Carbapenem-Resistant Pseudomonas aeruginosa Isolated from Patients with Urinary Tract Infections. Infect drug Resist 15:141\u2013151. https:\/\/doi.org\/10.2147\/IDR.S346313","journal-title":"Infect drug Resist"},{"issue":"10","key":"12025_CR5","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3201\/eid1710.110655","volume":"17","author":"P Nordmann","year":"2011","unstructured":"Nordmann P, Naas T, Poirel L (2011) Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 17(10):1791\u20131798. https:\/\/doi.org\/10.3201\/eid1710.110655","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"12025_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3934\/microbiol.2022013","volume":"8","author":"S Haghighi","year":"2022","unstructured":"Haghighi S, Reza Goli H (2022) High prevalence of blaVEB, blaGES and blaPER genes in beta-lactam resistant clinical isolates of Pseudomonas aeruginosa. AIMS Microbiol 8(2):153\u2013166. https:\/\/doi.org\/10.3934\/microbiol.2022013","journal-title":"AIMS Microbiol"},{"issue":"8","key":"12025_CR7","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/S1473-3099(22)00459-5","volume":"22","author":"VS Balakrishnan","year":"2022","unstructured":"Balakrishnan VS (2022) WHO\u2019s first global infection prevention and control report. Lancet Infect Dis 22(8):1122. https:\/\/doi.org\/10.1016\/S1473-3099(22)00459-5","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"12025_CR8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3390\/antibiotics12020328","volume":"12","author":"C Michaelis","year":"2023","unstructured":"Michaelis C, Grohmann E (2023) Horizontal gene transfer of antibiotic resistance genes in biofilms. Antibiot (Basel Switzerland) 12(2):328. https:\/\/doi.org\/10.3390\/antibiotics12020328","journal-title":"Antibiot (Basel Switzerland)"},{"key":"12025_CR9","doi-asserted-by":"publisher","first-page":"1231938","DOI":"10.3389\/fmicb.2023.1231938","volume":"14","author":"BA Bhat","year":"2023","unstructured":"Bhat BA, Mir RA, Qadri H, Dhiman R, Almilaibary A, Alkhanani M, Mir MA (2023) Integrons in the development of antimicrobial resistance: critical review and perspectives. Front Microbiol 14:1231938. https:\/\/doi.org\/10.3389\/fmicb.2023.1231938","journal-title":"Front Microbiol"},{"issue":"3","key":"12025_CR10","doi-asserted-by":"publisher","first-page":"e00202","DOI":"10.1128\/mSphere.00202-21","volume":"6","author":"M Al-Orphaly","year":"2021","unstructured":"Al-Orphaly M, Hadi HA, Eltayeb FK, Al-Hail H, Samuel BG, Sultan AA, Skariah S (2021) Epidemiology of multidrug-resistant Pseudomonas aeruginosa in the Middle East and North Africa Region. mSphere 6(3):e00202\u2013e00221. https:\/\/doi.org\/10.1128\/mSphere.00202-21","journal-title":"mSphere"},{"key":"12025_CR11","doi-asserted-by":"publisher","first-page":"1374466","DOI":"10.3389\/fmicb.2024.1374466","volume":"15","author":"A Elfadadny","year":"2024","unstructured":"Elfadadny A, Ragab RF, AlHarbi M, Badshah F, Ib\u00e1\u00f1ez-Arancibia E, Farag A, Hendawy AO, De Los R\u00edos-Escalante PR, Aboubakr M, Zakai SA, Nageeb WM (2024) Antimicrobial resistance of Pseudomonas aeruginosa: navigating clinical impacts, current resistance trends, and innovations in breaking therapies. Front Microbiol 15:1374466. https:\/\/doi.org\/10.3389\/fmicb.2024.1374466","journal-title":"Front Microbiol"},{"issue":"1","key":"12025_CR12","doi-asserted-by":"publisher","first-page":"7176","DOI":"10.1038\/s41598-024-56254-4","volume":"14","author":"S Abdelaziz Abdelmoneim","year":"2024","unstructured":"Abdelaziz Abdelmoneim S, Ghazy M, Anwar Sultan R, Hassaan E, M. A., Anwar Mahgoub M (2024) Antimicrobial resistance burden pre and post-COVID-19 pandemic with mapping the multidrug resistance in Egypt: a comparative cross-sectional study. Sci Rep 14(1):7176. https:\/\/doi.org\/10.1038\/s41598-024-56254-4","journal-title":"Sci Rep"},{"issue":"4","key":"12025_CR13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3390\/ph17040407","volume":"17","author":"AL Golli","year":"2024","unstructured":"Golli AL, Zlatian OM, Cara ML, Olteanu M (2024) Pre- and Post-COVID-19 Antimicrobial resistance pattern of pathogens in an intensive care unit. Pharmaceuticals (Basel Switzerland) 17(4):407. https:\/\/doi.org\/10.3390\/ph17040407","journal-title":"Pharmaceuticals (Basel Switzerland)"},{"key":"12025_CR14","volume-title":"David Hendricks), 1860\u20131937. Bergey\u2019s Manual of Determinative Bacteriology: a Key for the Identification of Organisms of the Class Schizomycetes","author":"DH Bergey","year":"1923","unstructured":"Bergey DH (1923) (David Hendricks), 1860\u20131937. Bergey\u2019s manual of determinative bacteriology: a key for the identification of organisms of the class schizomycetes. The Williams & Wilkins Company, Baltimore"},{"key":"12025_CR15","unstructured":"CLSI (2024) Performance Standards for Antimicrobial Susceptibility Testing, 34th ed.; Clinical and Laboratory Standards Institute: Wayne, PA, USA"},{"key":"12025_CR16","unstructured":"CLSI (2023) Performance Standards for Antimicrobial Susceptibility Testing, 33rd ed.; Clinical and Laboratory Standards Institute: Wayne, PA, USA"},{"issue":"2","key":"12025_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1590\/S1516-89132012000200020","volume":"55","author":"GA Silva","year":"2012","unstructured":"Silva GA, Bernardi TL, Schaker PDC, Menegotto M, Valente P (2012) Rapid yeast DNA extraction by boiling and freeze-thawing without using chemical reagents and DNA purification. Braz Arch Biol Technol 55(2):319\u2013327. https:\/\/doi.org\/10.1590\/S1516-89132012000200020","journal-title":"Braz Arch Biol Technol"},{"issue":"2","key":"12025_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.mimet.2005.02.007","volume":"62","author":"B Dillon","year":"2005","unstructured":"Dillon B, Thomas L, Mohmand G, Zelynski A, Iredell J (2005) Multiplex PCR for screening of integrons in bacterial lysates. J Microbiol Methods 62(2):221\u2013232. https:\/\/doi.org\/10.1016\/j.mimet.2005.02.007","journal-title":"J Microbiol Methods"},{"issue":"6","key":"12025_CR19","doi-asserted-by":"publisher","first-page":"e0274322","DOI":"10.1128\/spectrum.02743-22","volume":"10","author":"DR Cameron","year":"2022","unstructured":"Cameron DR, Pitton M, Oberhaensli S, Schlegel K, Prod\u2019hom G, Blanc DS, Jakob SM, Que YA (2022) Parallel Evolution of Pseudomonas aeruginosa during a Prolonged ICU-Infection Outbreak. Microbiol Spectr 10(6):e0274322. https:\/\/doi.org\/10.1128\/spectrum.02743-22","journal-title":"Microbiol Spectr"},{"key":"12025_CR20","doi-asserted-by":"publisher","first-page":"1543509","DOI":"10.3389\/fmicb.2025.1543509","volume":"16","author":"L Zhao","year":"2025","unstructured":"Zhao L, Pu J, Liu Y, Cai H, Han M, Yu Y, Tang J (2025) High prevalence of carbapenem-resistant Pseudomonas aeruginosa and identification of a novel VIM-type metallo-\u03b2-lactamase, VIM-92, in clinical isolates from northern China. Front Microbiol 16:1543509. https:\/\/doi.org\/10.3389\/fmicb.2025.1543509","journal-title":"Front Microbiol"},{"issue":"1","key":"12025_CR21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.21608\/mjmr.2024.272878.1681","volume":"36","author":"H Ali","year":"2025","unstructured":"Ali H, Omran A, Saedii A, Abd El-hakeem M (2025) Carbapenem resistant strains of Pseudomonas aeruginosa among patients in Minia University hospitals. Minia J Med Res 36(1):90\u201394. https:\/\/doi.org\/10.21608\/mjmr.2024.272878.1681","journal-title":"Minia J Med Res"},{"issue":"6","key":"12025_CR22","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3390\/antibiotics14060539","volume":"14","author":"RS Althaferi","year":"2025","unstructured":"Althaferi RS, Alfouzan WA, Mustafa AS (2025) Antibiotics resistance profile of clinical isolates of Pseudomonas aeruginosa obtained from farwaniya hospital in kuwait using phenotypic and molecular methods. Antibiot (Basel Switzerland) 14(6):539. https:\/\/doi.org\/10.3390\/antibiotics14060539","journal-title":"Antibiot (Basel Switzerland)"},{"key":"12025_CR23","doi-asserted-by":"publisher","first-page":"765113","DOI":"10.3389\/fmicb.2021.765113","volume":"12","author":"M Doumith","year":"2022","unstructured":"Doumith M, Alhassinah S, Alswaji A, Alzayer M, Alrashidi E, Okdah L, Aljohani S, Surveillance Group NGHAAMR, Balkhy HH, Alghoribi MF (2022) Genomic characterization of carbapenem-non-susceptible Pseudomonas aeruginosa clinical isolates from saudi arabia revealed a global dissemination of GES-5-Producing ST235 and VIM-2-Producing ST233 Sub-Lineages. Front Microbiol 12:765113. https:\/\/doi.org\/10.3389\/fmicb.2021.765113","journal-title":"Front Microbiol"},{"key":"12025_CR24","doi-asserted-by":"publisher","first-page":"1599070","DOI":"10.3389\/fmicb.2025.1599070","volume":"16","author":"T Ramatla","year":"2025","unstructured":"Ramatla T, Nkhebenyane J, Lekota KE, Thekisoe O, Monyama M, Achilonu CC, Khasapane G (2025) Global prevalence and antibiotic resistance profiles of carbapenem-resistant Pseudomonas aeruginosa reported from 2014 to 2024: a systematic review and meta-analysis. Front Microbiol 16:1599070. https:\/\/doi.org\/10.3389\/fmicb.2025.1599070","journal-title":"Front Microbiol"},{"issue":"8","key":"12025_CR25","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.3390\/microorganisms11081918","volume":"11","author":"E Serretiello","year":"2023","unstructured":"Serretiello E, Manente R, Dell\u2019Annunziata F, Folliero V, Iervolino D, Casolaro V, Perrella A, Santoro E, Galdiero M, Capunzo M, Franci G, Boccia G (2023) Antimicrobial Resistance in Pseudomonas aeruginosa before and during the COVID-19 Pandemic. Microorganisms 11(8):1918. https:\/\/doi.org\/10.3390\/microorganisms11081918","journal-title":"Microorganisms"},{"issue":"5","key":"12025_CR26","doi-asserted-by":"publisher","first-page":"e15724","DOI":"10.1016\/j.heliyon.2023.e15724","volume":"9","author":"Y Liu","year":"2023","unstructured":"Liu Y, Xu Y, Wang S, Zeng Z, Li Z, Din Y, Liu J (2023) Antibiotic susceptibility pattern, risk factors, and prediction of carbapenem-resistant Pseudomonas aeruginosa in patients with nosocomial pneumonia. Heliyon 9(5):e15724. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15724","journal-title":"Heliyon"},{"key":"12025_CR27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s42269-020-00350-8","volume":"44","author":"A Basha","year":"2020","unstructured":"Basha A, El-Sherbiny GM, Mabrouk MI (2020) Phenotypic characterization of the Egyptian isolates extensively drug-resistant Pseudomonas aeruginosa and detection of their metallo-\u03b2-lactamases encoding genes. Bull Natl Res Cent 44:117. https:\/\/doi.org\/10.1186\/s42269-020-00350-8","journal-title":"Bull Natl Res Cent"},{"issue":"1","key":"12025_CR28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12866-025-03946-0","volume":"25","author":"MH Salem","year":"2025","unstructured":"Salem MH, Azmy AF, Dishisha T, Dessouky N (2025) Pseudomonas aeruginosa clinical isolates in Egypt: phenotypic, genotypic, and antibiofilm assessment of Pluronic F-127. BMC Microbiol 25(1):245. https:\/\/doi.org\/10.1186\/s12866-025-03946-0","journal-title":"BMC Microbiol"},{"issue":"3","key":"12025_CR29","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3390\/antibiotics14030322","volume":"14","author":"P Chotimakorn","year":"2025","unstructured":"Chotimakorn P, Pattharachayakul S, Lertsrisatit Y, Santimaleeworagun W, Tansakul P, Yingkajorn M, Chelae S, Pomwised R, Chukamnerd A, Soontarach R, Chusri S (2025) Antimicrobial resistance and mortality in carbapenem-resistant Pseudomonas aeruginosa infections in Southern Thailand. Antibiot (Basel Switzerland) 14(3):322. https:\/\/doi.org\/10.3390\/antibiotics14030322","journal-title":"Antibiot (Basel Switzerland)"},{"issue":"5","key":"12025_CR30","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3390\/antibiotics10050548","volume":"10","author":"MG Wang","year":"2021","unstructured":"Wang MG, Liu ZY, Liao XP, Sun RY, Li RB, Liu Y, Fang LX, Sun J, Liu YH, Zhang RM (2021) Retrospective data insight into the global distribution of carbapenemase-producing Pseudomonas aeruginosa. Antibiot (Basel Switzerland) 10(5):548. https:\/\/doi.org\/10.3390\/antibiotics10050548","journal-title":"Antibiot (Basel Switzerland)"},{"key":"12025_CR31","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1186\/s12879-024-10123-7","volume":"24","author":"WM Abdelraheem","year":"2024","unstructured":"Abdelraheem WM, Ismail DE, Hammad SS (2024) Prevalence of blaOXA-48 and other carbapenemase encoding genes among carbapenem-resistant Pseudomonas aeruginosa clinical isolates in Egypt. BMC Infect Dis 24:1278. https:\/\/doi.org\/10.1186\/s12879-024-10123-7","journal-title":"BMC Infect Dis"},{"issue":"11","key":"12025_CR32","doi-asserted-by":"publisher","first-page":"e0287762","DOI":"10.1371\/journal.pone.0287762","volume":"18","author":"MT Arowolo","year":"2023","unstructured":"Arowolo MT, Orababa OQ, Olaitan MO, Osibeluwo BV, Essiet UU, Batholomew OH, Ogunrinde OG, Lagoke OA, Soriwei JD, Ishola OD, Ezeani OM, Onishile AO, Olumodeji E (2023) Prevalence of carbapenem resistance in Acinetobacter baumannii and Pseudomonas aeruginosa in sub-Saharan Africa: A systematic review and meta-analysis. PLoS ONE 18(11):e0287762. https:\/\/doi.org\/10.1371\/journal.pone.0287762","journal-title":"PLoS ONE"},{"issue":"4","key":"12025_CR33","doi-asserted-by":"publisher","first-page":"160","DOI":"10.21608\/mjmr.2022.270692","volume":"33","author":"A Saedii","year":"2022","unstructured":"Saedii A, Ahmed A, Mohamed O (2022) Carbapenem-resistant strains of Pseudomonas species at Minia University Hospitals. Minia J Med Res 33(4):160\u2013165. https:\/\/doi.org\/10.21608\/mjmr.2022.270692","journal-title":"Minia J Med Res"},{"key":"12025_CR34","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1186\/s12879-025-10891-w","volume":"25","author":"D Salem","year":"2025","unstructured":"Salem D, El-Shenawy A, Dahroug H et al (2025) Assessment of in vitro antimicrobial activities of ceftolozane\/tazobactam and ceftazidime\/avibactam against carbapenem-resistant Pseudomonas aeruginosa clinical isolates. BMC Infect Dis 25:622. https:\/\/doi.org\/10.1186\/s12879-025-10891-w","journal-title":"BMC Infect Dis"},{"issue":"4","key":"12025_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.12816\/0030399","volume":"24","author":"M Azab","year":"2015","unstructured":"Azab M, Shehata A, Mohamed M (2015) OXA-10 and GES-1 Extended-spectrum \u03b2-lactamases play a major role in causing antibiotic resistance of Pseudomonas aeruginosa Isolated from Nosocomial Infections in Ismailia, Egypt. Egypt J Med Microbiol 24(4):81\u201388. https:\/\/doi.org\/10.12816\/0030399","journal-title":"Egypt J Med Microbiol"},{"issue":"6","key":"12025_CR36","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1007\/s15010-024-02297-8","volume":"52","author":"EA Edward","year":"2024","unstructured":"Edward EA, Shehawy E, Abouelfetouh MR, A., Aboulmagd E (2024) Phenotypic and molecular characterization of extended spectrum- and metallo- beta lactamase producing Pseudomonas aeruginosa clinical isolates from Egypt. Infection 52(6):2399\u20132414. https:\/\/doi.org\/10.1007\/s15010-024-02297-8","journal-title":"Infection"},{"issue":"1","key":"12025_CR37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.21608\/ejmm.2024.317144.1325","volume":"34","author":"R Mostafa","year":"2025","unstructured":"Mostafa R, El fakhrany A, Ahmed F, Abd el kareem H, Soliman A, Khalil H, Sharfeldin A (2025) Prevalence of carbapenem resistance and antibacterial potential of nanoparticles in pseudomonas aeruginosa isolated from burn units in egypt. Egypt J Med Microbiol 34(1):45\u201353. https:\/\/doi.org\/10.21608\/ejmm.2024.317144.1325","journal-title":"Egypt J Med Microbiol"},{"issue":"4","key":"12025_CR38","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/microorganisms9040786","volume":"9","author":"F Nitz","year":"2021","unstructured":"Nitz F, de Melo BO, da Silva LC, de Souza Monteiro A, Marques SG, Monteiro-Neto V, de Jesus Gomes Turri R, Junior AD, Concei\u00e7\u00e3o PC, Magalh\u00e3es HJ, Zagmignan A (2021) Molecular Detection of Drug-Resistance Genes of blaOXA-23-blaOXA-51 and mcr-1 in Clinical Isolates of Pseudomonas aeruginosa. Microorganisms 9(4):786. https:\/\/doi.org\/10.3390\/microorganisms9040786","journal-title":"Microorganisms"},{"issue":"1","key":"12025_CR39","doi-asserted-by":"publisher","first-page":"100351","DOI":"10.1016\/j.jgeb.2024.100351","volume":"22","author":"FA Afify","year":"2024","unstructured":"Afify FA, Shata AH, Aboelnaga N, Osama D, Elsayed SW, Saif NA, Mouftah SF, Shawky SM, Mohamed AA, Loay O, Elhadidy M (2024) Emergence of carbapenem resistant gram-negative pathogens with high rate of colistin resistance in Egypt: A cross sectional study to assess resistance trends during the COVID-19 pandemic. J genetic Eng Biotechnol 22(1):100351. https:\/\/doi.org\/10.1016\/j.jgeb.2024.100351","journal-title":"J genetic Eng Biotechnol"},{"issue":"1","key":"12025_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.15407\/microbiolj86.01.003","volume":"86","author":"A Alfarras","year":"2024","unstructured":"Alfarras A, Al-Daraghi W (2024) Characterization of integron genes of clinical isolates of Pseudomonas aeruginosa which perform resistance to antibiotics and biofilm formation by these strains. Mikrobiol Z 86(1):3\u201313. https:\/\/doi.org\/10.15407\/microbiolj86.01.003","journal-title":"Mikrobiol Z"},{"key":"12025_CR41","doi-asserted-by":"publisher","DOI":"10.21608\/mid.2025.383744.2776","author":"Z lrawi","year":"2025","unstructured":"lrawi Z, Ali O, Taha R, Mashaly M (2025) Impact of efflux pump (ade F and G) and integron (Class 1 and 2) genes on antimicrobial resistance in Acinetobacter baumannii. Microbes Infect Dis. https:\/\/doi.org\/10.21608\/mid.2025.383744.2776","journal-title":"Microbes Infect Dis"},{"issue":"8","key":"12025_CR42","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1093\/bioinformatics\/btp105","volume":"25","author":"A Moura","year":"2009","unstructured":"Moura A, Soares M, Pereira C, Leit\u00e3o N, Henriques I, Correia A (2009) INTEGRALL: a database and search engine for integrons, integrases and gene cassettes. Bioinf (Oxford England) 25(8):1096\u20131098. https:\/\/doi.org\/10.1093\/bioinformatics\/btp105","journal-title":"Bioinf (Oxford England)"},{"key":"12025_CR43","doi-asserted-by":"publisher","first-page":"614058","DOI":"10.3389\/fmicb.2021.614058","volume":"12","author":"EJ Yoon","year":"2021","unstructured":"Yoon EJ, Jeong SH (2021) Mobile Carbapenemase Genes in Pseudomonas aeruginosa. Front Microbiol 12:614058. https:\/\/doi.org\/10.3389\/fmicb.2021.614058","journal-title":"Front Microbiol"},{"issue":"1","key":"12025_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.18683\/germs.2024.1413","volume":"14","author":"AM Sultan","year":"2024","unstructured":"Sultan AM, Mahmoud NM (2024) Detection of resistance integrons among biofilm and non-biofilm producing clinical isolates of Pseudomonas aeruginosa. Germs 14(1):11\u201319. https:\/\/doi.org\/10.18683\/germs.2024.1413","journal-title":"Germs"},{"issue":"4","key":"12025_CR45","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/1120009X.2022.2031468","volume":"34","author":"MME Abd-Elmonsef","year":"2022","unstructured":"Abd-Elmonsef MME, Maxwell SY (2022) Class 1, 2 and 3 integrons in clinical Pseudomonas aeruginosa isolated from Tanta University Hospitals, Egypt. J Chemother 34(4):241\u2013246. https:\/\/doi.org\/10.1080\/1120009X.2022.2031468","journal-title":"J Chemother"},{"key":"12025_CR46","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.3389\/fmicb.2020.01390","volume":"11","author":"C Xu","year":"2020","unstructured":"Xu C, Wang D, Zhang X, Liu H, Zhu G, Wang T, Cheng Z, Wu W, Bai F, Jin Y (2020) Mechanisms for rapid evolution of carbapenem resistance in a clinical isolate of Pseudomonas aeruginosa. Front Microbiol 11:1390. https:\/\/doi.org\/10.3389\/fmicb.2020.01390","journal-title":"Front Microbiol"},{"issue":"3","key":"12025_CR47","doi-asserted-by":"publisher","first-page":"123","DOI":"10.21103\/Article13(3)_OA12","volume":"13","author":"S Mohamed","year":"2023","unstructured":"Mohamed S, Ahmed Z, Mubarak T, Mohamed S, Mohamed R, Higazi H, Ali S (2023) Co-occurrence of carbapenemase genes blaNDM, blaVIM, blaKPC, and blaOXA-48 in Pseudomonas aeruginosa clinical isolates. Int J Biomed 13(3):123\u2013126","journal-title":"Int J Biomed"},{"issue":"1","key":"12025_CR48","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12866-024-03319-z","volume":"24","author":"SS Abdelrahim","year":"2024","unstructured":"Abdelrahim SS, Hassuna NA, Waly NGFM, Kotb DN, Abdelhamid H, Zaki S (2024) Coexistence of plasmid-mediated quinolone resistance (PMQR) and extended-spectrum beta-lactamase (ESBL) genes among clinical Pseudomonas aeruginosa isolates in Egypt. BMC Microbiol 24(1):175. https:\/\/doi.org\/10.1186\/s12866-024-03319-z","journal-title":"BMC Microbiol"},{"issue":"1","key":"12025_CR49","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s40121-020-00369-4","volume":"10","author":"R Wasfi","year":"2021","unstructured":"Wasfi R, Rasslan F, Hassan SS, Ashour HM, Abd El-Rahman OA (2021) Co-existence of carbapenemase-encoding genes in Acinetobacter baumannii from cancer patients. Infect Dis therapy 10(1):291\u2013305. https:\/\/doi.org\/10.1007\/s40121-020-00369-4","journal-title":"Infect Dis therapy"},{"key":"12025_CR50","doi-asserted-by":"publisher","first-page":"1283583","DOI":"10.3389\/fcimb.2023.1283583","volume":"13","author":"M Beig","year":"2023","unstructured":"Beig M, Badmasti F, Solgi H, Nikbin VS, Sholeh M (2023) Carbapenemase genes distribution in clonal lineages of Acinetobacter baumannii: a comprehensive study on plasmids and chromosomes. Front Cell Infect Microbiol 13:1283583. https:\/\/doi.org\/10.3389\/fcimb.2023.1283583","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"12025_CR51","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12929-019-0603-0","volume":"27","author":"H Lee","year":"2020","unstructured":"Lee H, Shin J, Chung YJ, Park M, Kang KJ, Baek JY, Shin D, Chung DR, Peck KR, Song JH, Ko KS (2020) Co-introduction of plasmids harbouring the carbapenemase genes, blaNDM-1 and blaOXA-232, increases fitness and virulence of bacterial host. J Biomed Sci 27(1):8. https:\/\/doi.org\/10.1186\/s12929-019-0603-0","journal-title":"J Biomed Sci"},{"key":"12025_CR52","doi-asserted-by":"publisher","first-page":"1208046","DOI":"10.3389\/fcimb.2023.1208046","volume":"13","author":"S S\u00e1nchez-Urtaza","year":"2023","unstructured":"S\u00e1nchez-Urtaza S, Ocampo-Sosa A, Molins-Bengoetxea A, El-Kholy MA, Hernandez M, Abad D, Shawky SM, Alkorta I, Gallego L (2023) Molecular characterization of multidrug resistant Acinetobacter baumannii clinical isolates from Alexandria, Egypt. Front Cell Infect Microbiol 13:1208046. https:\/\/doi.org\/10.3389\/fcimb.2023.1208046","journal-title":"Front Cell Infect Microbiol"},{"key":"12025_CR53","doi-asserted-by":"publisher","first-page":"1332736","DOI":"10.3389\/fcimb.2023.1332736","volume":"13","author":"S S\u00e1nchez-Urtaza","year":"2024","unstructured":"S\u00e1nchez-Urtaza S, Ocampo-Sosa A, Rodr\u00edguez-Grande J, El-Kholy MA, Shawky SM, Alkorta I, Gallego L (2024) Plasmid content of carbapenem resistant Acinetobacter baumannii isolates belonging to five International Clones collected from hospitals of Alexandria, Egypt. Front Cell Infect Microbiol 13:1332736. https:\/\/doi.org\/10.3389\/fcimb.2023.1332736","journal-title":"Front Cell Infect Microbiol"},{"key":"12025_CR54","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1186\/s12879-025-11185-x","volume":"25","author":"S Salem","year":"2025","unstructured":"Salem S, Osama D, Abdelsalam NA et al (2025) Comparative genomics of Acinetobacter baumannii from Egyptian healthcare settings reveals high-risk clones and resistance gene mobilization. BMC Infect Dis 25:803. https:\/\/doi.org\/10.1186\/s12879-025-11185-x","journal-title":"BMC Infect Dis"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12025-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12025-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12025-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:20:18Z","timestamp":1780485618000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12025-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12025"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12025-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"27 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Research Ethics Committee, Minia University, Faculty of Medicine Institutional Review Board (MUFMIRB Approval No. 1115\/03\/2024). The MUFMIRB operates in accordance with the ethical principles outlined in the Declaration of Helsinki and the guidelines of the Council for International Organizations of Medical Sciences (CIOMS). Informed consent was obtained from all participants for the use of their clinical samples in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"881"}}